scispace - formally typeset
J

John Lusingu

Researcher at National Institute for Medical Research

Publications -  140
Citations -  8518

John Lusingu is an academic researcher from National Institute for Medical Research. The author has contributed to research in topics: Malaria & Plasmodium falciparum. The author has an hindex of 42, co-authored 126 publications receiving 7235 citations. Previous affiliations of John Lusingu include Health Science University & Copenhagen University Hospital.

Papers
More filters
Journal ArticleDOI

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Selidji T Agnandji, +150 more
TL;DR: The RTS,S/AS01 vaccine provided protection against both clinical and severe malaria in African children, and serious adverse events occurred with a similar frequency in the two study groups.
Journal ArticleDOI

National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010

TL;DR: The burden of small-for-gestational-age births is very high in countries of low and middle income and is concentrated in south Asia.
Journal ArticleDOI

Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure

TL;DR: This work compared the prevalence of IgG antibodies with three Plasmodium falciparum asexual stage antigens in individuals of all ages living at varying altitudes encompassing a range of transmission intensities from hyper- to hypoendemic in northeastern Tanzania, with alternative measures of transmission intensity.
Journal ArticleDOI

Severe malaria is associated with parasite binding to endothelial protein C receptor

TL;DR: EPCR, which mediates the cytoprotective effects of activated protein C, is identified as the endothelial receptor for DC8 and DC13 PfEMP1, and it is shown that EPCR binding is mediated through the amino-terminal cysteine-rich interdomain region (CIDRα1) ofDC8 and group A Pf EMP1 subfamilies, and that CIDR α1 interferes with protein C binding to EPCC.